Dear Dr. Renukaprasad A R,  How does abemaciclib hold a pivotal role in the life of hormone receptor-positive (HR+)/ human epidermal growth factor receptor-2 negative (HER2-) in metastatic breast cancer (MBC) women with poor prognoses? Attend this exclusive webinar on September 20, 2022, at 7:30 PM IST with our oncology experts, Dr. Anwar Al Nouri (Kuwait), Dr. T.P. Sahoo, Dr. Chandrakanth M. V., Dr. P.N. Mohapatra, Dr. Bharat A. Vaswani, and Dr. Madhuchanda Kar as they discuss how abemaciclib can be a game changer for MBC patients with poor prognosis. Your questions will be answered live by the experts during the Q&A session. We anticipate your participation in this insightful conversation. | 
No comments:
Post a Comment